vTv Therapeutics Inc. (VTVT): insider trading, Congress trades & who owns it

Insider signal
50/100
Neutral · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$0
0 sellers · 12 months
Funds holding
45
13F · Q2 2026
Congress trades
None
none in 2 years

Quiet on the insider front: nobody at vTv Therapeutics Inc. bought or sold VTVT shares in open-market trades this past year.

45 investment managers listed VTVT in their latest 13F filings (Q2 2026); more funds bought than sold. Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.

Want the full picture on VTVT? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full VTVT report — free account

Latest insider trades in VTVT

FiledInsiderRoleTypeSharesPriceValueSource
Nov 19, 2024SEKHRI PAUL JCEOBuy1,778$16.88$30KSEC
Nov 19, 2024SEKHRI PAUL JCEOBuy1,844$16.96$31KSEC
Nov 19, 2024SEKHRI PAUL JCEOBuy1,378$16.35$23KSEC

Questions about VTVT

Are insiders buying or selling VTVT stock?

There were no open-market insider trades in VTVT in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

How many institutions own VTVT?

45 investment managers reported holding VTVT in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded VTVT?

No congressional trades in VTVT were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).